Selective serotonin reuptake inhibitor or serotonin-norepinephrine reuptake inhibitors and epidemiological characteristics associated with prenatal diagnosis of congenital heart disease.
Sarah Jane MelovPrayatna Singh ShettyDharmintra PasupathyAdrienne KirbyGary F ShollerDavid S WinlawThushari I AlahakoonPublished in: Prenatal diagnosis (2020)
Our data show maternal mood disorders with and without SSRI or SNRI use, maternal age >40 years and lack of multivitamin/folate use to be independently associated with CHD in pregnancy.